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The role of protein kinase A in regulating transcription of the cholinergic gene locus, which contains both
the vesicular acetylcholine transporter gene and the choline acetyltransferase gene, was investigated in PC12
cells and a protein kinase A-deficient PC12 mutant, A126.1B2, in which transcription of the gene is reduced.
The site of action of protein kinase A was localized to a neuron-restrictive silencer element/repressor element
1 (NRSE/RE-1) sequence within the cholinergic gene. Neuron-restrictive silencer factor (NRSF)/RE-1-silencing
transcription factor (REST), the transcription factor which binds to NRSE/RE-1, was expressed at similar
levels in both PC12 and A126.1B2 cells. Although nuclear extracts containing NRSF/REST from A126.1B2
exhibited binding to NRSE/RE-1, nuclear extracts from PC12 cells did not. The NRSF/REST isoform REST4
was expressed in PC12 cells but not in A126.1B2. REST4 inhibited binding of NRSF/REST to NRSE/RE-1 as
determined by gel mobility shift assays. Coimmunoprecipitation was used to demonstrate interaction between
NRSF/REST and REST4. Expression of recombinant REST4 in A126.1B2 was sufficient to transcriptionally
activate the cholinergic gene locus. Thus, in PC12 cells, protein kinase A promotes the production of REST4,
which inhibits repression of the cholinergic gene locus by NRSF/REST.
The cholinergic gene locus contains the genes for both the
enzyme choline acetyltransferase (ChAT; EC 2.3.1.6) and the
vesicular acetylcholine transporter (VAChT) (1, 2, 5). ChAT is
the enzyme responsible for the biosynthesis of the neurotrans-
mitter acetylcholine, while VAChT is the vesicle membrane
transporter that translocates cytoplasmic acetylcholine to the
interior of synaptic vesicles. ChAT and VAChT are both re-
quired for cholinergic neurotransmission.
Previous reports showed that the ChAT gene contains three
59 noncoding exons: exon 1, named the R exon; exon 2, named
the N exon; and exon 3, named the M exon. The three exons
result in multiple 59 mRNA species, which are produced from
different promoters and by alternative mRNA splicing (14, 18,
30). The VAChT gene lies uniquely within the first intron of
the ChAT gene, between the R and N exons, and has the same
transcriptional orientation. Multiple VAChT mRNA species
with different 59 noncoding exons have also been reported, and
some of these share the R exon with ChAT mRNA species.
This organization of the ChAT and VAChT genes is suggested
to lead to coordinate regulation of the two genes at the tran-
scriptional level (2, 3, 9, 19, 25). Although the mechanism of
transcriptional regulation controlling the cholinergic gene lo-
cus is poorly understood, a neuron-restrictive silencer element/
repressor element 1, (NRSE/RE-1) sequence is implicated in
silencing the cholinergic gene locus in nonneuronal cells (16).
The NRSE/RE-1, which comprises ;23 nucleotides, is found
in a number of neuron-specific genes, including the type II
sodium channel (7), synapsin I (15), SCG10 (20), Ng-CAM
(13), and the m4 muscarinic receptor (17), to name but a few.
The transcription factor that binds to the NRSE sequence,
the neuron-restrictive silencer factor (NRSF) or RE-1-silenc-
ing transcription factor (REST), is a 210-kDa glycoprotein
containing nine zinc finger domains (7). It was reported that
NRSF/REST bound to the NRSE and repressed the expres-
sion of neuron-specific genes in nonneuronal cell lines (24). It
was also found that NRSF/REST could act as a silencer of
neuron-specific gene expression in undifferentiated neuronal
progenitor cells (6, 7, 24). Recently, it was reported that several
NRSF/REST splice variants were expressed in mature neurons
of adult brain, albeit at low levels (21). The neuron-specific
isoforms have an insertion of either 16 nucleotides (REST4) or
28 nucleotides (REST5) in the region of the gene encoding the
spacer between zinc fingers 5 and 6. These splice variants lead
to truncated proteins containing only five zinc fingers. The
physiological function of these splice variants has been, until
now, unclear.
Our previous studies using PC12 cells and protein kinase A
(PKA)-deficient mutant PC12 cells suggested that PKA signal-
ing pathways regulate the transcription of the cholinergic gene
locus. The site of interaction was proposed to reside in the 59
noncoding region of the cholinergic gene locus upstream of the
VAChT gene (12, 25). To study further the role of PKA in
regulating the cholinergic gene locus, we focused on the role of
this kinase in regulating NRSF/REST activity. The results sug-
gest that in PC12 cells, PKA controls the expression of the
neuron-specific isoform REST4, produced by alternative splic-
ing of NRSF/REST. REST4 appears to regulate cholinergic
gene expression by forming a complex with NRSF/REST,
thereby preventing the binding of the latter to the NRSE/RE-1
sequence.
MATERIALS AND METHODS
Materials. RNase inhibitor and DNase I were purchased from Boehringer
Mannheim (Indianapolis, Ind.). Deoxyribonucleotides, Dulbecco’s modified Ea-
gle’s medium (DMEM), fetal bovine serum (FBS), Geneticin (G418), horse
serum, and Superscript II reverse transcriptase were obtained from Gibco BRL
(Gaithersburg, Md.). Oligonucleotide primers were synthesized with a Beckman
Oligo1000 DNA synthesizer or purchased from commercial sources. [g-32P]ATP,
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[a-32P]dCTP, and [3H]acetyl coenzyme A were from ICN Pharmaceuticals (Ir-
vine, Calif.). Taq bead hot-start polymerase was purchased from Promega (Mad-
ison, Wis.). The bicinchoninic acid (BCA) protein assay kit was obtained from
Pierce (Rockford, Ill.). poly(dI-dC) z poly(dI-dC) and random hexamers [pd(N)6]
were obtained from Pharmacia Biotech (Piscataway, N.J.). The ECL1Plus West-
ern blotting detection system and Hybond-P membranes were purchased from
Amersham Life Science Inc. (Arlington Heights, Ill.). SuperFect transfection
reagent, plasmid kits, and RNeasy MINI kits (Total RNA system) were obtained
from Qiagen Inc. (Valencia, Calif.). The GalactoLight system was purchased
from Tropix Inc. (Bedford, Mass.). The pcDNA3 vector was obtained from
Invitrogen, while pXP2 was obtained from the American Type Culture Collec-
tion. All other reagents were from Sigma Chemical Co. (St. Louis, Mo.) and were
of the highest quality available.
Cell lines and cell culture. The cell lines used in this study were a wild-type
parental PC12 cell line and a PC12 mutant cell line, A126.1B2, generated by
using nitrosoguanidine (29). The A126.1B2 cell line has an overall reduced level
of cytosolic PKA activity and is devoid of nuclear PKA activity (4). Cells were
routinely grown in DMEM supplemented with 10% heat-inactivated FBS and
5% heat-inactivated horse serum at 37°C in a humidified atmosphere of 90% air
and 10% CO2. The medium was changed every 3 days, and cells were harvested
and subcultured every 6 days. HEK293 cells were cultured in DMEM containing
10% heat-inactivated FBS.
Antisera. A monoclonal antibody (MAb) to mouse NRSF/REST, 12C11-1,
was generated as previously described (6). A rabbit antiserum against the cata-
lytic subunit of PKA (23) was a generous gift of Y. Fukami, Kobe University,
Kobe, Japan. A MAb against the myc epitope, a goat anti-myc epitope immu-
noglobulin G (IgG) coupled to agarose, a goat anti-FLAG epitope IgG coupled
to agarose, and normal goat IgG coupled to agarose were purchased from Santa
Cruz Biotechnology Inc. (Santa Cruz, Calif.).
Electrophoretic mobility shift assays. Nuclear extracts from cells were pre-
pared as described by Lonnerberg et al. (16) except for the inclusion of addi-
tional protease inhibitors: 20 mM leupeptin, 0.5 mM phenylmethylsulfonyl flu-
oride, 0.5 mM benzamidine, 1 mg of pepstatin/ml, and 18 mg of aprotinin/ml.
DNA fragments were end labeled with [g-32P]ATP by using T4 polynucleotide
kinase. For binding, 10 mg of nuclear protein was preincubated on ice, with or
without a 100-fold excess of unlabeled competitor DNA, for 10 min in 20 ml of
a solution containing 20 mM HEPES (pH 7.6), 0.1% Nonidet P-40, 10% glycerol,
1 mM dithiothreitol, 2.5 mM MgCl2, 250 mM KCl, and 2 mg of poly(dI-dC) z
poly(dI-dC). Labeled oligonucleotide (100 fmol) was mixed with nuclear protein,
and the mixture was incubated for 10 min at 25°C. For supershift assays, 10 mg
of nuclear protein was preincubated on ice with or without MAb 12C11-1 for 30
min before addition of the labeled probe. The reaction mixture was loaded onto
a 6% nondenaturing polyacrylamide gel with 0.253 Tris-borate-EDTA (TBE)
buffer. The ChAT NRSE/RE-1 and control oligonucleotides described by Lon-
nerberg et al. (16) were used in these studies.
Western blot analysis. Nuclear extract (100 mg) was solubilized in Laemmli
sample buffer. After separation on a reducing sodium dodecyl sulfate (SDS)-
polyacrylamide gel (7%), proteins were transferred onto a Hybond-P membrane
as described previously (28). The membrane was then incubated with anti-NRSF
MAb (12C11-1), followed by horseradish peroxidase-labeled goat anti-mouse
antiserum, and visualized by using an ECL1Plus detection kit as per the man-
ufacturer’s instructions.
RNA preparations and RT-PCR. Total RNA was prepared from cell lines by
using RNeasy kits. The recovery of RNA was quantified spectrophotometrically.
RNA was digested with DNase I to eliminate contaminating endogenous DNA.
Single-stranded cDNAs were synthesized with Superscript II reverse transcrip-
tase, using random hexamers [pd(N)6] as primers. Each PCR cycle consisted of
94°C for 1 min, 55°C for 1 min, and 72°C for 1 min, followed by a 5-min extension
at 72°C. PCR products were separated in a 1.5% agarose gel with TBE buffer;
this was followed by ethidium bromide staining. Primers used were as follows:
rNRSF-S, GACAGGTTCACAACGGGCC; rNRSF-AS, CCCTTCGGCACTT
CGCCGCT; p2-S, CTACATGGCACACCTGAAGCACCAC; pR4-AS, GGCT
TCTCACCCAACTAGATCACACT; Actin-S, ATTCCTATGTGGGCGACG
AG; and Actin-AS, TGGATAGCAACGTACATGGC.
For ChAT and VAChT, single-stranded cDNAs were synthesized by using
specific primers for VAChT or ChAT (25). PCR was performed with 1/10 volume
of reverse transcription (RT) mixture in a 50-ml reaction volume that included
deoxynucleoside triphosphates (10 nmol each), appropriate sense and antisense
primers (10 pmol), [a-32P]dCTP (1.67 pmol), and Taq polymerase in a buffer
supplied by the manufacturer. After an initial denaturation at 94°C for 5 min,
each PCR cycle included 94°C for 1 min, 55°C for 1 min, and 72°C for 1 min, with
variable numbers of cycles. After completion of the desired number of PCR
cycles, a 5-min extension at 70°C was performed. PCR products were electro-
phoresed on a 5% polyacrylamide gel with TBE followed by autoradiography.
Enzyme activity assays. ChAT activity was assayed by a modification of the
method of Fonnum as described previously (11). The protein concentrations of
cell extracts were determined with a BCA protein assay kit (Pierce). Cyclic AMP
(cAMP)-dependent PKA activity was measured as described previously (25).
Construction and expression of PKA catalytic subunit. The Chinese hamster
ovary cell PKA catalytic subunit b (Catb) or a mutated form of Catb (CatbM)
(kindly provided by R. Maurer) was cloned into the multiple cloning site of the
pcDNA3 mammalian expression vector. Transfections were carried out with
SuperFect transfection reagent according to the manufacturer’s protocol. Briefly,
104 A126.1B2 cells on a 100-mm-diameter plate were first washed twice with
DMEM. Ten micrograms of pcDNA3-Catb or pcDNA3-CatbM and 50 ml of
SuperFect transfection reagent were mixed in 300 ml of serum-free DMEM, and
the cells were incubated in this mixture for 3 h. Subsequently, the medium was
discarded, the cells were washed with phosphate-buffered saline, and fresh me-
dium was added. After 3 days, the medium was changed to one containing 800 mg
of G418/ml, and after 3 weeks, clonal cell lines were isolated by using cloning
wells.
Reporter gene assays. Fragments of the human cholinergic gene were inserted
into the multiple cloning site of the pXP2 vector. Thus, pXP2NX is a derivative
of pXP2 containing a 1,156-bp NheI-XhoI fragment of the human cholinergic
gene upstream of the VAChT gene. pXP2EX is a similar construct but contains
a 2,200-bp 59 extension of the NheI-XhoI fragment. After transfection of these
constructs into cells by using SuperFect reagent, cell lysates were prepared, and
luciferase activity in these lysates was measured by a luminescence assay (25).
b-Galactosidase activity was measured by using the GalactoLight system accord-
ing to the manufacturer’s procedure. Luminescence was detected by using an
Opticomp I luminometer (GEM Biomedical, Inc.)
Expression of NRSF/REST and REST4. The mouse full-length NRSF cDNA
or that of the truncated isoform REST4 was inserted into the pCS21MT ex-
pression vector, which added five myc epitope tags to its N terminus (22). The
inserts were cloned from an NcoI to an XbaI site by using primers that added
these sites to the ends of the cDNA. The truncated form of REST, REST4, was
prepared by PCR amplification with a forward primer (ATGGCCACCCAGGT
GATG) and a reverse primer (TCACCCAACTAGATCACACTCTGAGTGA
GTACGCATGTG) including REST4-specific sequences. The PCR product, am-
plified with Pfu polymerase, was gel purified and subcloned into the SmaI site of
pBluescriptII KS(1); this was followed by digestion with PstI and XbaI. The
fragment (PstI-XbaI) of pCS21MTNRSF was removed and replaced with the
PstI-XbaI fragment of pBluescript-REST4. A second REST4 construct was pre-
pared in which the five N-terminal myc epitope tags were replaced with a FLAG
epitope tag to yield pCS21FLAGREST4. The sequences of PCR products were
confirmed by DNA sequencing. Constructs were transfected into HEK293 cells
by using SuperFect transfection reagent in accordance with the instructions in
the manufacturer’s manual. After 72 h, cells were harvested and nuclear extracts
were prepared as described above.
Immunoprecipitation. HEK293 cells were transfected, using SuperFect trans-
fection reagent, with either pCS21MTNRSF or FLAG epitope-tagged REST4,
pCS21 FLAGREST4. The cells were cultured for 3 days after transfection, and
then collected, and nuclear extracts were prepared as described above. Each
nuclear extract was preincubated with normal goat IgG coupled to agarose at 4°C
for 2 h, and the supernatant was obtained by centrifugation. The supernatant was
subjected to immunoprecipitation with goat anti-myc IgG conjugated to agarose
or goat anti-FLAG IgG conjugated to agarose, with gentle rotation at 4°C for
16 h. The immunoprecipitate was collected by centrifugation, solubilized with
SDS-polyacrylamide gel electrophoresis (PAGE) sample buffer, resolved by
SDS-PAGE, and subjected to Western blot analysis with the NRSF MAb
12C11-1.
RESULTS
Previous studies have shown that the level of transcription of
the cholinergic gene locus, comprising the ChAT gene and the
VAChT gene, is greatly reduced in two mutant PC12 cell lines
(12, 25), A123.7 (8, 10) and A126.1B2 (29), which both exhibit
reduced PKA activity. We tested the effect of introducing the
catalytic subunit of PKA (Catb) into the mutant PC12 cell line
A126.1B2. This cell line, which was generated by nitrosogua-
nidine mutagenesis, fails to accumulate Catb in the nucleus
and, although exhibiting normal levels of Catb in the cytosol,
has reduced cytosolic PKA activity (4). We have generated
A126.1B2 cell lines stably transfected with Catb (A126.1B2Catb)
or a mutated inactive CatbM (A126.1B2CatbM). In agreement
with the findings of Cassano et al. (4), we found that the
parental and A126.1B2 cell lines contained similar cytosolic
levels of the catalytic subunit of PKA; however, only the pa-
rental cell line contained the nuclear catalytic subunit. The
nuclear PKA catalytic subunit was expressed at comparable
levels in A126.1B2Catb and A126.1B2CatbM (Fig. 1). The spe-
cific activity of PKA in the A126.1B2Catb cell line, measured
with a synthetic peptide substrate, was increased from 0.6 to
3.6 nmol of 32P incorporated/min/mg of protein, while the
specific activity of ChAT was increased from 2.7 to 18.8 pmol
of acetylcholine formed/min/mg of protein (Fig. 2). There was
no change in the specific activity of PKA or ChAT in
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A126.1B2CatbM. The PKA inhibitor H89 reduced both PKA
activity and ChAT activity in the parental cell line. The ability
to increase ChAT activity in the A126.1B2 cell line to parental
levels clearly demonstrates that the ChAT gene is intact in this
cell line. Furthermore, these results demonstrate that PKA
alone is sufficient to restore ChAT activity.
We next investigated whether PKA might regulate transcrip-
tion of the ChAT gene through elements in the 59 upstream
region of the gene. We tested reporter gene constructs which
contained fragments of the human cholinergic gene and lucif-
erase as a reporter gene: a 1,156-bp NheI-XhoI fragment re-
ferred to as pXP2NX and a 3,356-bp EcoRI-XhoI fragment
referred to as pXP2EX. The construct pXP2NX contains a
basal VAChT promoter from the cholinergic locus (31), while
pXP2EX contains an additional 2,200 bp of upstream se-
quence including the NRSE/RE-1. The NRSE/RE-1 is the
silencer element that mediates negative regulation of a number
of neuronal genes. We also used a construct, pXP2EX-m, in
which the NRSE/RE-1 was inactivated by mutagenesis. Figure
3 shows the results of a typical transient-transfection experi-
ment with these constructs. In the parental PC12 cell line,
expression of the reporter gene from pXP2EX was somewhat
reduced compared to that from pXP2NX, and this effect was
eliminated by mutation of the NRSE. The PKA inhibitor H89
had no significant effect on the basal promoter in pXP2NX but
inhibited expression of the pXP2EX construct. In contrast,
H89 had no effect on the pXP2EX-m construct, which contains
the inactive mutant NRSE. These results suggest that the
NRSE/RE-1 is minimally active in the parental PC12 cell line
and that inhibition of PKA decreases transcription of the gene
dependent on the region of the gene containing the NRSE. In
the PKA-deficient PC12 cell line A126.1B2, the reporter gene
activity of the extended fragment pXP2EX containing the
NRSE was greatly reduced. Reporter gene activity could be
restored by mutation of the NRSE, while addition of a PKA
inhibitor had no effect on the pXP2EX-m construct. The ex-
pression pattern seen in A126.1B2Catb recapitulated that of the
parental cell line, while the expression pattern in A126.1B2CatbM
was the same as that seen in A126.1B2. These results provide
evidence that PKA can increase transcription of the cholin-
ergic gene locus by acting through the NRSE/RE-1 repressor
element.
Preliminary evidence previously obtained suggested that
PKA might regulate the activity of NRSF/REST (25). Thus,
we analyzed NRSF/REST expression in nuclear extracts
prepared from wild-type PC12, A126.1B2, A126.1B2Catb, or
A126.1B2CatbM cells by Western blot analysis with an anti-
NRSF MAb, using the ECL1Plus detection system. As shown
in Fig. 4A, comparable levels of NRSF/REST immunoreactive
protein were detected in all of the PC12 cell lines, although the
level of NRSF/REST present in PC12 cells was considerably
lower than that observed in nonneuronal cell lines such as NIH
3T3 and HeLa. Since the levels of NRSF/REST were approx-
imately the same in all of the PC12 cell lines examined, the
effect of PKA cannot be attributed to regulation of NRSF/
REST gene transcription, NRSF/REST mRNA stability, or
NRSF/REST protein turnover.
The DNA binding activity of NRSF/REST in nuclear ex-
tracts from the various cell lines was analyzed by determining
the ability to bind to an oligonucleotide containing the human
ChAT NRSE in an electrophoretic mobility shift assay. A gel
FIG. 1. Expression of the PKA catalytic subunit in the cytosolic and nuclear
fractions of PC12 cell lines. Nuclear and cytosolic extracts (10 mg) from the
indicated cell lines were subjected to SDS-PAGE followed by Western blot
analysis with a rabbit anti-PKA catalytic subunit antibody and then detection by
enhanced chemiluminescence.
FIG. 2. PKA activity and ChAT activity in control cells and cells transfected with the PKA catalytic b subunit. A126.1B2 cells stably transfected with either the
plasmid pcDNA3-Catb, containing the catalytic subunit of PKA (A126.1B2Catb), or the plasmid pcDNA3-CatbM, containing an inactive catalytic subunit of PKA
(A126.1B2CatbM), were grown in DMEM containing G418. The medium was changed every 3 days, and cells were subcultured every 6 days. After 3 weeks, cells were
harvested and lysates were prepared. Also shown are results obtained with untreated wild-type PC12 cells and wild-type PC12 cells treated for 3 days with 10 mM H89.
ChAT and PKA activity were assayed as described in Materials and Methods. Data are means 6 standard errors of the means (n 5 6). pp, P , 0.01 versus the respective
control value (Student’s t test).
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shift band was barely detectable with a nuclear extract from
wild-type PC12 cells (Fig. 4B), consistent with the lack of
repression of the cholinergic gene in this cell line. However, a
prominent gel shift band was detected for the A126.1B2 cell
line, in which transcription of the cholinergic gene is repressed.
The gel shift band was also detected in nuclear extracts from
A126.1B2CatbM, but not in nuclear extracts from
A126.1B2Catb. Binding was competed by an excess of cold
NRSE oligonucleotide but not by an unrelated sequence (data
not shown). Furthermore, the gel shift band could be super-
shifted with an anti-NRSF antibody (Fig. 4C). Thus, although
NRSF/REST is expressed in both wild-type and mutant PC12
cells, only nuclear extracts derived from PKA-deficient PC12
cells show significant binding to the NRSE/RE-1. This finding
is consistent with the observation that PKA-deficient PC12
cells exhibit repressed levels of ChAT activity and of ChAT
and VAChT mRNAs.
We examined the possibility that PKA directly phosphory-
lates NRSF/REST by incubating recombinant NRSF with the
catalytic subunit of PKA in the presence of [g-32P]ATP and the
phosphatase inhibitor sodium vanadate. Analysis of the prod-
ucts by radioautography following SDS-PAGE failed to reveal
the presence of 32P-labeled NRSF. The same results were
obtained when we tested REST4 (see below) as a substrate for
PKA. In this experiment, the catalytic subunit of PKA was
shown to be active by its ability to phosphorylate the synthetic
peptide substrate Leu-Arg-Arg-Ala-Ser-Leu-Gly.
We thus looked for alternative mechanisms that might lead
to the regulation of NRSF/REST activity by PKA. Recently, it
was reported that a multiple splicing pattern of NRSF/REST
mRNA occurred (21), leading to novel isoforms. Two of these
splice variants, referred to as REST4 and REST5, were found
to be neuron-specific NRSF/REST truncated isoforms ex-
pressed in adult brain neurons (21). We used RT-PCR to
detect the presence of these isoforms in the wild-type PC12,
A126.1B2, A126.1B2CatbM, and A126.1B2Catb cell lines. Total
RNA was prepared from these cell lines and transcribed with
random hexamers; this was followed by PCR amplification with
oligonucleotide primers specific for the neuron-specific NRSF
sequences.
As shown in Fig. 5A, a PCR product was detected in all cell
lines by using primer pairs specific for NRSF/REST. On the
other hand, a PCR product for the neuron-specific isoform
REST4 was detected in PC12 and A126.1B2Catb but not in
A126.1B2 or A126.1B2CatbM. The PKA inhibitor H89 blocked
the expression of REST4 in PC12 cells (Fig. 5A). REST4
mRNA was induced within 4 h of treatment of PC12 cells with
10 mM forskolin, an adenylate cyclase activator, and appeared
to reach a maximal level by 6 h (Fig. 5B). ChAT mRNA was
also induced by forskolin, but an increase was just detectable at
FIG. 3. Transient-transfection assays using the 59 noncoding region of the human ChAT gene driving the luciferase reporter gene. A schematic showing the 59
noncoding region of the human cholinergic gene and the constructs generated from this region is shown on the bottom. The position of the VAChT gene is indicated,
while R represents the first exon of the cholinergic gene. The positions of restriction sites for EcoRI, NheI, and XhoI are shown. Constructs were named on the basis
of the restriction fragment inserted into the pXP2 vector, with N corresponding to the NheI site, X corresponding to the XhoI site, and E corresponding to the EcoRI
site. PXP2EX-m contains a mutated inactive NRSE. H89 is a PKA inhibitor. Constructs were transiently transfected into the indicated cell lines as described in
Materials and Methods. After 48 h, cells were harvested, and extracts prepared from them were subsequently assayed for luciferase activity. Luciferase activity was
normalized to b-galactosidase activity.
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6 h and a maximum was reached at 12 h (Fig. 5B). In contrast,
NRSF/REST mRNA was unaffected by forskolin.
We attempted to estimate the relative levels of NRSF/REST
and REST4 in PC12 cells. A low level of NRSF/REST was
detectable by Western blot analysis, as shown in Fig. 4A; how-
ever, REST4 was difficult to detect, and its level appeared to be
at or just below our detection limits. Thus, there is more
endogenous NRSF/REST than REST4, although as noted
REST4 mRNA levels can be increased by agents that lead to
the activation of PKA. The presence of excess NRSF/REST
relative to REST4 is supported by the data in Fig. 3, which
show that expression of a reporter gene containing the NRSE/
RE-1 is partially repressed in PC12 cells.
No PCR product was detected in any cell line when primer
pairs specific for the isomer REST5 were used. These data
suggest that PKA activity, presumably nuclear PKA activity, is
required for the production of the REST4 isoform. Further-
more, the presence or absence of REST4 mRNA, but not
NRSF/REST, correlates with transcription of the cholinergic
gene.
To study whether the neuron-specific isoform REST4 binds
to the NRSE sequence, we performed electrophoretic mobility
shift assays using recombinant NRSF/REST and REST4 ex-
pressed in HEK293 cells. As shown in Fig. 6A, the expected gel
shift band was detected with nuclear extracts containing
NRSF/REST (lane 1). No gel shift band was detected with
nuclear extracts containing REST4 (lane 2). However, when a
FIG. 4. NRSE binding activity in PC12 and A126.1B2 cell lines. (A) Elec-
trophoretic mobility shift assay. Nuclear cell extracts prepared from the indicated
cell lines were analyzed for binding to the cholinergic NRSE/RE-1 by electro-
phoretic mobility shift assays. (B) Western blot analysis of NRSF. Nuclear
extracts (100 mg) from each cell line were subjected to SDS-PAGE followed by
Western blotting with an anti-NRSF MAb and detection with the ECL1Plus
detection system. PC12 cells were treated with 10 mM H89 as for Fig. 2. (C)
Supershifting of NRSE/RE-1 gel shift band. Electrophoretic mobility shift assays
were conducted as described for panel B except that the nuclear extract was
preincubated with 2 mg of anti-NRSF MAb or 2 mg of a control MAb prepared
against mouse ChAT where indicated.
FIG. 5. Analysis of NRSF/REST and REST4 mRNA expression in PC12 and
A126.1B2 cell lines and the effect of forskolin. (A) NRSF/REST and REST4
mRNA levels in PC12 cell lines. PCR was performed with primer pairs specific
for NRSF/REST, REST4, and actin as described in Materials and Methods. The
bottom pattern is a control in which the primer pairs for REST4 were used
without RT of RNA. PC12 cells were treated with H89 as described in the legend
to Fig. 2. (B) Effect of forskolin on NRSF/REST, REST4, and ChAT mRNAs.
PC12 cells were untreated (2) or were treated with 10 mM forskolin (1) for the
time periods indicated. PCR was performed as described in Materials and Meth-
ods.
6792 SHIMOJO ET AL. MOL. CELL. BIOL.
nuclear extract containing REST4 was mixed with a nuclear
extract containing full-length NRSF/REST, the gel shift band
was eliminated (lane 3). No such effect was seen with nuclear
extracts from control HEK293 cells. Western blotting verified
the presence of NRSF/REST or REST4 in nuclear extracts.
Increasing the amount of REST4 progressively diminished the
binding of NRSF/REST to the NRSE/RE-1 sequence (Fig.
6C). In contrast, a slight increase in the intensity of the gel shift
band was seen with increasing amounts of nuclear extract from
vector-transfected HEK293 cells. This slight increase presum-
ably reflects the endogenous NRSF/REST.
Since REST4 interferes with the binding of NRSF/REST to
the NRSE, we looked for a direct interaction between REST4
and NRSF/REST. As shown in Fig. 7, mixing of an N-termi-
nally myc-tagged NRSF/REST with an N-terminally FLAG-
tagged REST4 led to the immunoprecipitation of both proteins
with either an anti-myc antiserum or an anti-FLAG antiserum.
To determine whether expression of REST4, in the absence
of nuclear PKA, is sufficient to transcriptionally activate the
ChAT gene, we transiently transfected the A126.1B2 cell line
with recombinant REST4. As shown in Fig. 8A, this led to an
approximately fourfold increase in ChAT activity in this cell
line, with a concomitant increase in ChAT mRNA (Fig. 8B).
VAChT mRNA levels also increased, but to a lesser extent
(Fig. 8B).
DISCUSSION
Utilizing mutant PC12 cell lines which have reduced levels of
PKA activity, we previously found that basal transcription of
the ChAT and VAChT genes is regulated coordinately by PKA
(25). In this study, we have shown that reintroduction of PKA
activity into one of these PC12 cell lines, A126.1B2, can restore
ChAT activity.
Studies conducted with reporter gene constructs further
demonstrate that the effect of PKA is at the transcriptional
level and that the action of PKA requires an intact NRSE/
RE-1 sequence. This element, which is though to be responsi-
ble for silencing the activity of a number of neuronal genes in
nonneuronal cells, has been shown to be active in the cholin-
ergic gene locus (16). The observation that the concentrations
of the transcription factor that binds to the NRSE/RE-1,
NRSF/REST, are essentially the same in the parental and PKA
mutant PC12 cell lines indicates that PKA does not affect the
levels of this transcription factor. On the other hand, electro-
phoretic mobility shift assays indicate that the NRSF/REST in
the PKA-deficient cell line can bind to the NRSE/RE-1 se-
quence. In contrast, nuclear extracts derived from the wild-
type PC12 cell line exhibited barely detectable binding to the
NRSE/RE-1 sequence despite the fact that these extracts con-
tain the same levels of NRSF/REST immunoreactive protein.
Restoration of PKA activity in the PKA-deficient cell line
resulted in a loss of the ability of the NRSF/REST to bind to
the NRSE/RE-1.
The finding of an active NRSF/REST in the PKA-deficient
FIG. 6. REST4 inhibits binding of NRSF/REST to the NRSE element of the
cholinergic gene. (A) Electrophoretic mobility shift assays performed with nu-
clear extracts from HEK293 cells expressing NRSF/REST (lane 1), REST4 (lane
2), and a 1:1 mixture of the two extracts (lane 3). (B) Western blot analysis of
HEK293 cells transfected with NRSF/REST or REST4. The positions of molec-
ular mass markers are shown on the right. (C) Electrophoretic mobility shift
assays performed with 10 mg of a nuclear extract from HEK293 cells expressing
NRSF and increasing amounts (0 to 10 mg) of a HEK293 nuclear extract ex-
pressing REST4 (1REST4) or control plasmid (2REST4). The arrow indicates
the gel shift band produced by the binding of NRSF/REST to the NRSE from the
cholinergic gene. The faster-moving gel shift band is a nonspecific band seen in
all experiments.
FIG. 7. REST4 forms a hetero-oligomer with NRSF/REST. Nuclear extracts
were prepared from HEK293 cells expressing either FLAG-REST4 or myc-
NRSF/REST. The individual extracts or a mixture of the two were subjected to
immunoprecipitation (IP) with either an immobilized goat IgG to the FLAG
epitope (FLAG), an immobilized goat IgG to the myc epitope (Myc), or immo-
bilized nonimmune goat IgG (NI). The resulting samples were subjected to
SDS-PAGE and probed with MAb 12C11-1, which is directed against the N-
terminal region of NRSF/REST and thus recognizes both NRSF/REST and
REST4. The bands corresponding to REST4 and NRSF/REST are indicated.
The positions of molecular mass markers are shown on the left.
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cell line can thus account for the low ChAT activity in these
cells, caused by repression of the cholinergic gene locus by this
transcription factor. The fact that the catalytic subunit of PKA
can lead to an apparently inactive NRSF/REST and concom-
itantly increase ChAT gene expression indicates that the ac-
tions of PKA can be solely explained by a PKA signaling
pathway regulating NRSF function. Labeling experiments sug-
gest that PKA does not directly phosphorylate NRSF/REST.
In contrast to the finding that full-length NRSF/REST is
expressed in both the parental and the PKA mutant PC12 cell
lines, the alternatively spliced REST4 isoform is expressed only
in the parental cell line. REST4 is formed by the utilization of
an alternative exon between exons V and VI of the NRSF/
REST gene, which introduces a stop codon (21). Thus, REST4
contains only five of the nine zinc finger domains found in
NRSF/REST.
Expression of the PKA catalytic subunit in the mutant PC12
cell line induced expression of REST4, and the direct intro-
duction of REST4, in the absence of PKA, mimicked the
action of PKA on the cholinergic gene. In other words, the
expression of exogenous REST4 was sufficient to rescue the
mutation in PKA and restore expression of ChAT, bypassing
the requirement for PKA activity.
The effect of PKA can be accounted for by its regulation of
the splicing of the NRSF/REST gene to produce the REST4
isoform. In this regard, the defect in the mutant PC12 cell line
A126.1B2 is an absence of nuclear PKA activity. This localiza-
tion is consistent with a role for PKA in regulating NRSF/
REST splicing, although we do not yet know whether regula-
tion is direct or indirect. Treatment of PC12 cells with
forskolin, which increases intracellular cAMP levels by activat-
ing adenylate cyclase, induced REST4 mRNA within 4 h and
ChAT mRNA within 6 to 12 h. The kinetics of forskolin in-
duction is consistent with PKA first increasing REST4 levels,
which in turn leads to increased levels of ChAT mRNA.
We have shown that although REST4 itself does not bind to
the NRSE, it acts as a dominant negative by inhibiting the
binding of NRSF/REST to the NRSE sequence. Dominant-
negative forms of NRSF/REST, generated by both N- and
C-terminal truncation of NRSF/REST such that there are
eight DNA binding zinc finger domains, have been generated
and utilized (6, 7). Palm et al. (21) found that REST2-5trunc
acted as a transcriptional repressor of a reporter gene in
Neuro-2A cells, which do not contain detectable NRSF/REST.
Relatively weak repression of the reporter gene was seen in C6
cells, which contain relatively high levels of endogenous NRSF/
REST. They concluded that the truncated forms of REST
produce repression independent of the activity of endogenous
NRSF/REST and that the repressor activity of the truncated
forms resides in an N-terminal repressor (26, 27). It was sug-
gested (21) that the repressor activity of truncated forms of
REST such as REST4 might result from their formation of a
complex with essential components of the transcription ma-
chinery.
Our data show that REST4 acts as a dominant negative. The
mechanism by which REST4 acts as a dominant negative can
be accounted for, at least in part, by the physical interaction,
either direct or indirect, between REST4 and NRSF/REST.
Consistent with the results shown in Fig. 4B and C and 6C, the
complex containing REST4 and NRSF/REST cannot bind to
the NRSE.
The finding that REST4 can act as a dominant negative,
coupled with its expression in neuronal cells, can account for
the presence of NRSF/REST in neuronal cells without its re-
pressing neuronal gene expression. Palm et al. (21) reported
the presence of NRSF/REST in adult neurons, albeit at rather
low levels relative to its expression in nonneuronal cells. Both
Palm et al. (21) and Thiel et al. (27) suggested that the inability
of NRSF/REST to repress gene expression in neurons could be
explained by its low concentration. Although this is one possi-
ble reason, we propose a second mechanism: that REST4,
which is found coexpressed with NRSF/REST in neurons,
modulates NRSF/REST as a transcriptional repressor of neu-
ronal genes in neurons. Thus, the relative levels of NRSF/
REST and REST4 determine the extent of transcriptional re-
pression. Although NRSF/REST levels appear to be constant
in PC12 cells, we found that the levels of REST4 mRNA
respond to effectors of cAMP levels and PKA activity. Thus, at
least in the PC12 cell line that we studied, the cholinergic gene
was not maximally active since there was an excess of NRSF/
REST relative to REST4. The transcriptional activity of the
cholinergic gene can thus be regulated by basal levels of PKA,
and the levels of REST4 can be increased or decreased by
effectors of PKA. This mechanism, rather than acting on a
cAMP response element, can explain the effects of cAMP on
cholinergic gene expression in PC12 cells. Since REST4 is only
expressed in neurons (21), its action is limited to these cells.
Whether this mechanism can be extended to cholinergic and
other neurons in vivo remains to be determined.
In summary, our results suggest that REST4 itself does not
act as a transcriptional repressor but rather regulates the re-
FIG. 8. ChAT activity and ChAT and VAChT mRNAs in A126.1B2 cells
transfected with REST4. (A) A126.1B2 was transfected with pCS21MT-REST4
(1REST4) or vector alone (2REST4), using SuperFect transfection reagent.
After 72 h, cell extracts were prepared and assayed for REST4 expression by
Western blot analysis (top) or for ChAT activity (bottom) as described in Ma-
terials and Methods. (B) PCR analysis for ChAT mRNA (30 cycles) and VAChT
mRNA (35 cycles) of A126.1B2 treated as described above.
6794 SHIMOJO ET AL. MOL. CELL. BIOL.
pressor activity of NRSF/REST. We propose that this mecha-
nism be called the antisilencer mechanism of gene regulation.
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